A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] |
Schwartz, Gary, MD |
A Phase IB/II Study Evaluating Doxorubicin with or without a IMC-3G3 to Treat Advanced Soft-Tissue Sarcoma
[Protocol 10-156] |
Tap, William, MD |
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104] |
Tap, William, MD |
A Phase IB/II Study of Imatinib Plus Everolimus in Synovial Sarcoma
[Protocol 10-167] |
Keohan, Mary, MD |
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] |
Trippett, Tanya, MD |
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094] |
Dickson, Mark, MD |
A Phase II Study of Temsirolimus and IGF-1 receptor antibody IMC-A12 in Patients with Metastatic Sarcomas
[Protocol 09-097] |
Schwartz, Gary, MD |
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
[Protocol 03-099] |
Wexler, Leonard, MD |
A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026] |
Wexler, Leonard, MD |
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] |
Hensley, Martee, MD |
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091] |
Magnan, Heather, MD |
The Evaluation of Pazopanib for Treating Recurrent or Persistent Carcinosarcoma of the Uterus
[Protocol 11-064] |
Hensley, Martee, MD |
